Article
Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis.
Journal of molecular medicine (Berlin, Germany) - 1 Jul 2012
Chang Yi-Cheng, Liu Pi-Hua, Tsai Yun-Chih, Chiu Yen-Feng, Shih Shyang-Rong, Ho Low-Tone, Lee Wen-Jane, Lu Chieh-Hua, Quertermous Thomas, Curb J David, Lee Wei-Jei, Lee Po-Chu, He You-Han, Yeh Jih-I, Hwang Juey-Jen, Tsai Shu-Huei, Chuang Lee-Ming
Abstract excerpt
Prostaglandins are potent modulators of insulin sensitivity. We systemically evaluated the association of 61 tag single-nucleotide polymorphisms (SNP) in 14 genes involved in prostaglandin metabolism with type 2 diabetes. Among all genotyped SNPs, rs10483032 in the CBR3 (carbonyl reductase 3) gene, which encodes for an enzyme converting prostaglandin E(2) to prostaglandin F2(α), was associated with type 2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
